Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial

IMPORTANCE: To date, extended-release naltrexone hydrochloride has not previously been compared directly with opioid medication treatment (OMT), currently the most commonly prescribed treatment for opioid dependence. OBJECTIVE: To determine whether treatment with extended-release naltrexone will be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Psychiatry
Main Authors: Tanum, Lars, Solli, Kristin Klemmetsby, Latif, Zill-e-Huma, Benth, Jūratė Šaltytė, Opheim, Arild, Sharma-Haase, Kamni, Krajci, Peter, Kunøe, Nikolaj
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583381/
https://ncbi.nlm.nih.gov/pubmed/29049469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2017.3206
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados